GHRS GH Research PLC
GHRS GH Research PLC
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-08-17 1 bull converging
POC $13.03 · VWAP $17.95 · +67.0% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
GHRS Price Structure
Loading timeframes…
Peers
Every watchlist GHRS belongs to, members best 30-day change first — GHRS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported EPS $-0.23 versus analyst consensus of $-0.30 (+24.2%).
full note →Against street estimates
How GHRS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
GHRS research tape
10 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.